Quince Therapeutics, Inc.
QNCX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662774
No open-market purchases or sales by Quince Therapeutics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $4.74M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Quince Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −4 vs. Q1 2023
- Shares held
- 8.98M
- +1.30M (+16.9%) vs. Q1 2023
- Total value
- $13.5M
- +$1.53M (+12.8%) vs. Q1 2023
- New holders
- 5
- 7 more added
- Sold out
- 9
- 10 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QNCX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $4.74M |
| Q1 2026 | 46 | $1.44M |
| Q4 2025 | 67 | $67.5M |
| Q3 2025 | 45 | $19.2M |
| Q2 2025 | 41 | $12.5M |
| Q1 2025 | 36 | $6.96M |
| Q4 2024 | 35 | $9.55M |
| Q3 2024 | 33 | $4.04M |
| Q2 2024 | 43 | $4.68M |
| Q1 2024 | 46 | $7.71M |
| Q4 2023 | 44 | $7.83M |
| Q3 2023 | 42 | $8.40M |
| Q2 2023 | 40 | $13.5M |
| Q1 2023 | 45 | $12.0M |
| Q4 2022 | 50 | $3.44M |
| Q3 2022 | 61 | $12.4M |
| Q2 2022 | 70 | $26.0M |
| Q1 2022 | 88 | $99.5M |
| Q4 2021 | 102 | $242.8M |
| Q3 2021 | 131 | $1.76B |
| Q2 2021 | 105 | $982.9M |
| Q1 2021 | 91 | $673.5M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Quince Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tang Capital Management LLC | 3,613,280 | $5.44M | 0.80% | −6,720−0.2% | Reduced |
| BML Capital Management, LLC | 1,411,839 | $2.12M | 1.91% | +1,411,839 | New |
| EPIQ Capital Group, LLC | 933,180 | $1.40M | 0.74% | −25,289−2.6% | Reduced |
| Vanguard Group Inc | 893,291 | $1.34M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 339,715 | $511.3K | 0.00% | +15,809+4.9% | Added |
| Renaissance Technologies LLC | 288,700 | $434.0K | 0.00% | +58,900+25.6% | Added |
| Knightsbridge Asset Management, LLC | 228,605 | $344.0K | 0.11% | +228,605 | New |
| Two Sigma Advisers, LP | 191,189 | $287.7K | 0.00% | −213,811−52.8% | Reduced |
| Alphabet Inc. | 189,122 | $285.6K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 187,162 | $281.7K | 0.00% | +50,076+36.5% | Added |
| Bank of America Corp | 162,939 | $245.2K | 0.00% | +147,691+968.6% | Added |
| Susquehanna International Group, LLP | 112,772 | $169.7K | 0.00% | −12,754−10.2% | Reduced |
| Two Sigma Investments, LP | 69,529 | $104.6K | 0.00% | −57,557−45.3% | Reduced |
| Millennium Management LLC | 61,407 | $92.4K | 0.00% | −186,606−75.2% | Reduced |
| State Street Corp | 56,611 | $85.2K | 0.00% | −800−1.4% | Reduced |
| Bridgeway Capital Management, LLC | 55,000 | $82.8K | 0.00% | −55,000−50.0% | Reduced |
| Intellectus Partners, LLC | 53,527 | $80.6K | 0.02% | +53,527 | New |
| Northern Trust Corp | 43,858 | $66.0K | 0.00% | +3,436+8.5% | Added |
| Strategic Blueprint, LLC | 12,200 | $18.4K | 0.00% | 00.0% | Unchanged |
| Cohen Lawrence B | 11,126 | $16.7K | 0.01% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 11,013 | $16.6K | 0.00% | 00.0% | Unchanged |
| Westmount Partners, LLC | 10,148 | $15.3K | 0.01% | 00.0% | Unchanged |
| Brinker Capital Investments, LLC | 10,136 | $15.3K | 0.00% | 00.0% | Unchanged |
| Orion Portfolio Solutions, LLC | 10,136 | $15.3K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 7,249 | $10.9K | 0.00% | −2,445−25.2% | Reduced |
| Citigroup Inc | 5,165 | $7.77K | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 2,376 | $3.58K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 912 | $1.37K | 0.00% | +587+180.6% | Added |
| Royal Bank of Canada | 478 | $1.00K | 0.00% | +478 | New |
| JPMorgan Chase & Co | 469 | $706 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 394 | $592 | 0.00% | +394 | New |
| JDM Financial Group LLC | 340 | $512 | 0.00% | 00.0% | Unchanged |
| Financial Perspectives, Inc | 310 | $467 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 277 | $416 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 267 | $402 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 154 | $232 | 0.00% | +7+4.8% | Added |
| Barclays PLC | 100 | $151 | 0.00% | 00.0% | Unchanged |
| Financial Avengers, Inc. | 100 | $151 | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 75 | $113 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 59 | $89 | 0.00% | −588−90.9% | Reduced |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −46,840−100.0% | Sold out |
| Hennion & Walsh Asset Management, Inc. | 0 | $0 | 0.00% | −31,061−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −22,321−100.0% | Sold out |
| Quantamental Technologies LLC | 0 | $0 | 0.00% | −10,867−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −1,050−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −801−100.0% | Sold out |
| Ten Capital Wealth Advisors, LLC | 0 | $0 | 0.00% | −163−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −98−100.0% | Sold out |
| Householder Group Estate & Retirement Specialist, LLC | – | – | – | – | Not filed |